mRNA |
Bleomycin |
CTRPv2 |
pan-cancer |
AAC |
0.078 |
0.04 |
mRNA |
NG-25 |
GDSC1000 |
pan-cancer |
AAC |
-0.059 |
0.04 |
mRNA |
Rapamycin |
CTRPv2 |
pan-cancer |
AAC |
0.071 |
0.04 |
mRNA |
alisertib |
CTRPv2 |
pan-cancer |
AAC |
0.065 |
0.04 |
mRNA |
Epothilone B |
GDSC1000 |
pan-cancer |
AAC |
-0.069 |
0.04 |
mRNA |
prochlorperazine |
CTRPv2 |
pan-cancer |
AAC |
0.074 |
0.04 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.072 |
0.04 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.05 |
mRNA |
BMS-345541 |
CTRPv2 |
pan-cancer |
AAC |
0.072 |
0.05 |
mRNA |
Zibotentan |
GDSC1000 |
pan-cancer |
AAC |
-0.065 |
0.05 |